Crucell Switzerland (Vivotif Operations) Overview

  • Status
  • Acquired/​Merged
  • Employees
  • 80
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Crucell Switzerland (Vivotif Operations) General Information

Description

Provider of travel vaccines. The unit manufactures and distributes travel vaccines for typhoid and hepatitis A.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Biotechnology
Acquirer
PaxVax
Primary Office
  • Switzerland
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Crucell Switzerland (Vivotif Operations) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Crucell Switzerland (Vivotif Operations)‘s full profile, request access.

Request a free trial

Crucell Switzerland (Vivotif Operations) Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Crucell Switzerland (Vivotif Operations) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Crucell Switzerland (Vivotif Operations)‘s full profile, request access.

Request a free trial